The Efficacy and Cognitive Impact of Perampanel Monotherapy in Patients with Self-Limited Epilepsy with Centrotemporal Spikes: A Retrospective Analysis

References

• Sanlidag B, Köken ÖY, Temel EÜ, et al. Benign epilepsy with centrotemporal spikes: is there a thalamocortical network dysfunction present? Seizure. 2020;79:44–48.
   PubMed Web of Science ®Google Scholar
• Potschka H, Trinka E. Perampanel: does it have broad-spectrum potential? Epilepsia. 2019;60(Suppl 1):22–36. doi:10.1111/epi.14456
   PubMedGoogle Scholar
• Sills GJ, Rogawski MA. Mechanisms of action of currently used antiseizure drugs. Neuropharmacology. 2020;168:107966. doi:10.1016/j.neuropharm.2020.107966
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Gil-Nagel A, Wheless JW, et al. Perampanel monotherapy for the treatment of epilepsy: clinical trial and real-world evidence. Epilepsy Behav. 2022;136:108885. doi:10.1016/j.yebeh.2022.108885
   PubMed Web of Science ®Google Scholar
• Operto FF, Pastorino GMG, Mazza R, et al. Social cognition and executive functions in children and adolescents with focal epilepsy. Eur J Paediatr Neurol. 2020;28:167–175. doi:10.1016/j.ejpn.2020.06.019
   PubMed Web of Science ®Google Scholar
• Operto FF, Scuoppo C, Padovano C, et al. Migraine and epilepsy: social cognition skills in pediatric population. Eur J Paediatr Neurol. 2022;37:68–74. doi:10.1016/j.ejpn.2022.01.011
   PubMed Web of Science ®Google Scholar
• Pastorino GMG, Operto FF, Padovano C, et al. Social cognition in neurodevelopmental disorders and epilepsy. Front Neurol. 2021;12:658823. doi:10.3389/fneur.2021.658823
   PubMed Web of Science ®Google Scholar
• Operto FF, Vivenzio V, Scuoppo C, et al. Perampanel and visuospatial skills in children with epilepsy. Front Neurol. 2021;12:696946. doi:10.3389/fneur.2021.696946
   PubMed Web of Science ®Google Scholar
• Operto FF, Pastorino GMG, Di Bonaventura C, et al. Effects of antiseizure monotherapy on visuospatial memory in pediatric age. Eur J Paediatr Neurol. 2021;32:106–114. doi:10.1016/j.ejpn.2021.04.004
   PubMed Web of Science ®Google Scholar
• Pina-Garza JE, Lagae L, Villanueva V, et al. Long-term effects of adjunctive perampanel on cognition in adolescents with partial seizures. Epilepsy Behav. 2018;83:50–58.
   PubMed Web of Science ®Google Scholar
• Husni RE, Ngo LY, Senokuchi H, et al. Experience of perampanel monotherapy beyond initial titration to achieve seizure freedom in patients with focal-onset seizures with newly diagnosed or currently untreated recurrent epilepsy: a post hoc analysis of the open-label study 342 (FREEDOM). Epilepsia Open. 2022;7(1):59–66. doi:10.1002/epi4.12551
   PubMedGoogle Scholar
• Chinvarun Y. A retrospective, real-world experience of perampanel monotherapy in patient with first new onset focal seizure: a Thailand experience. Epilepsia Open. 2022;7(1):67–74. doi:10.1002/epi4.12555
   PubMedGoogle Scholar
• Yasumoto S, Shimizu M, Sato K, et al. Lamotrigine monotherapy for newly diagnosed typical absence seizures in children: a multi-center, uncontrolled, open-label study. Brain Dev. 2016;38(4):407–413. doi:10.1016/j.braindev.2015.10.007
   PubMed Web of Science ®Google Scholar
• Heller AJ, Chesterman P, Elwes RD, et al. Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial. J Neurol Neurosurg Psychiatry. 1995;58(1):44–50.
   PubMed Web of Science ®Google Scholar
• Glauser T, Ben‐Menachem E, Bourgeois B, et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2013;54(3):551–563.
   PubMed Web of Science ®Google Scholar
• Trinka E, Ben-Menachem E, Kowacs PA, et al. Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: a phase III double-blind, randomized, parallel-group, multicenter study. Epilepsia. 2018;59(2):479–491. doi:10.1111/epi.13993
   PubMed Web of Science ®Google Scholar
• Liang JP. Characteristics and interpretation of epilepsy classification in 2017 edition of the international league against epilepsy. Chin J Pract Pediatr. 2020;35(1):47–54.
   Google Scholar
• Miao Q, Wang XY, Zhang Q, et al. Application of event-related potential P300 in neurologic diseases with cognitive dysfunction. J Bengbu Med Coll. 2019;44(3):325–327.
   Google Scholar
• Zhang HM, Wen XH, Huang JH, et al. Application of Wechsler Intelligence Scale for Children Fourth Edition in cognitive assessment of children with epilepsy. Chin J Child Health. 2018;26(10):1120–1123.
   Google Scholar
• French JA, Krauss GL, Biton V, et al. Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304. Neurology. 2012;79(6):589–596. doi:10.1212/WNL.0b013e3182635735
   PubMed Web of Science ®Google Scholar
• French JA, Krauss GL, Steinhoff BJ, et al. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305. Epilepsia. 2013;54(1):117–125. doi:10.1111/j.1528-1167.2012.03638.x
   PubMed Web of Science ®Google Scholar
• Krauss GL, Serratosa JM, Villanueva V, et al. Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures. Neurology. 2012;78(18):1408–1415. doi:10.1212/WNL.0b013e318254473a
   PubMed Web of Science ®Google Scholar
• Gil-Nagel A, Burd S, Toledo M, et al. A retrospective, multicentre study of perampanel given as monotherapy in routine clinical care in people with epilepsy. Seizure. 2018;54:61–66. doi:10.1016/j.seizure.2017.10.015
   PubMed Web of Science ®Google Scholar
• Fang H, Hu W, Jiang Z, et al. Autoimmune glial fibrillary acidic protein astrocytopathy in children: a retrospective analysis of 35 cases. Front Immunol. 2021;12:761354. doi:10.3389/fimmu.2021.761354
   PubMed Web of Science ®Google Scholar
• Brodie MJ, Stephen LJ. Prospective audit with adjunctive perampanel: preliminary observations in focal epilepsy. Epilepsy Behav. 2016;54:100–103. doi:10.1016/j.yebeh.2015.11.002
   PubMed Web of Science ®Google Scholar
• Garamendi-Ruiz I, García-García ME, Bertol-Alegre V, et al. One-year clinical experience of perampanel in Spain: a multicentre study of efficacy and tolerability. Epileptic Disord. 2016;18(2):173–180. doi:10.1684/epd.2016.0824
   PubMed Web of Science ®Google Scholar
• Maurousset A, Limousin N, Praline J, et al. Adjunctive perampanel in refractory epilepsy: experience at tertiary epilepsy care center in tours. Epilepsy Behav. 2016;61:237–241. doi:10.1016/j.yebeh.2016.06.005
   PubMed Web of Science ®Google Scholar
• Villanueva V, Garcés M, López-González FJ, et al. Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: the FYDATA study. Epilepsy Res. 2016;126:201–210. doi:10.1016/j.eplepsyres.2016.08.001
   PubMed Web of Science ®Google Scholar
• Heyman E, Lahat E, Levin N, et al. Tolerability and efficacy of perampanel in children with refractory epilepsy. Dev Med Child Neurol. 2017;59(4):441–444. doi:10.1111/dmcn.13362
   PubMed Web of Science ®Google Scholar
• Datta AN, Xu Q, Sachedina S, et al. Clinical experience with perampanel for refractory pediatric epilepsy in one Canadian center. J Child Neurol. 2017;32(9):834–839. doi:10.1177/0883073817709195
   PubMed Web of Science ®Google Scholar
• Swiderska N, Tan HJ, Rajai A, et al. Effectiveness and tolerability of perampanel in children, adolescents and young adults with refractory epilepsy: a UK national multicentre study. Seizure. 2017;52:63–70. doi:10.1016/j.seizure.2017.08.014
   PubMed Web of Science ®Google Scholar
• Biro A, Stephani U, Tarallo T, et al. Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies: first experiences. Neuropediatrics. 2015;46(2):110–115. doi:10.1055/s-0035-1546276
   PubMed Web of Science ®Google Scholar
• Operto FF, Orsini A, Sica G, et al. Perampanel and childhood absence epilepsy: a real life experience. Front Neurol. 2022;13:952900. doi:10.3389/fneur.2022.952900
   PubMed Web of Science ®Google Scholar
• Steinhoff BJ, Hamer H, Trinka E, et al. A multicenter survey of clinical experiences with perampanel in real life in Germany and Austria. Epilepsy Res. 2014;108(5):986–988. doi:10.1016/j.eplepsyres.2014.03.015
   PubMed Web of Science ®Google Scholar
• Operto FF, Pastorino GMG, Mazza R, et al. Perampanel tolerability in children and adolescents with focal epilepsy: effects on behavior and executive functions. Epilepsy Behav. 2020;103(Pt A):106879. doi:10.1016/j.yebeh.2019.106879
   PubMedGoogle Scholar
• Witt JA, Helmstaedter C. The impact of perampanel on cognition: a systematic review of studies employing standardized tests in patients with epilepsy. Seizure. 2022;94:107–111. doi:10.1016/j.seizure.2021.12.001
   PubMed Web of Science ®Google Scholar